Clinical Trial Update: Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates the pharmacokinetics of a 48-hour sevoflurane inhalation delivered via the AnaConDa disposable system in ICU patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Acute Kidney Injury | Phase 2 | Status: UNKNOWN